— Ticker · NYQ —
RMD · ResMed Inc.
Healthcare · Medical Instruments & Supplies
RMD
$232.49
▼ -8.13%
7-day move
7-day move
day$230.35 → $233.2952-wk$180.27 → $277.67avg vol1.4M / 3Mcap$32.7B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 17.6 |
| P/E (trailing) | 21.2 |
| EPS (forward) | $13.24 |
| EPS (trailing) | $10.98 |
| PEG | 1.23 |
| Dividend | 1.15% |
The Risk
| Beta | 0.76 |
| Short % float | 8.51% |
| Float | 139.8M |
| Shares out | 140.7M |
| Avg vol (3M) | 1.4M |
| 52w range | $180.27 → $277.67 |
The Analyst Tape
strong buybuyholdunderperformsell
$265.11
avg 12-mo target
+14.0%
vs. last · 17 analysts
At a Glance
$32.7B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryMedical Instruments & Supplies
market cap$32.7B
websiteresmed.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for RMD in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for RMD.
Indicators That Mention RMD
8 of our 658 catalog map to RMD
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.03
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Healthcare · by market cap · 7-day move
— Voices on RMD —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning RMD. Opinion, not wire.
No recent commentary mentioning RMD in the last 7 days.
Analyst · previewYou're seeing the public read on RMD. Analyst unlocks every pundit call on RMD with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with RMD as the target + the API / MCP feed.Compare tiers →